Acutus Medical Inc (AFIB) 20 Days SMA touches 0.72%: The odds favor the bear

A new trading day began on Monday, with Acutus Medical Inc (NASDAQ: AFIB) stock price up 6.17% from the previous day of trading, before settling in for the closing price of $0.19. AFIB’s price has ranged from $0.16 to $1.64 over the past 52 weeks.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 82.03%. Meanwhile, its annual earnings per share averaged 27.06%. With a float of $18.68 million, this company’s outstanding shares have now reached $28.55 million.

Acutus Medical Inc (AFIB) Insider Activity

As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Acutus Medical Inc is 36.26%, while institutional ownership is 11.60%.

Acutus Medical Inc (AFIB) Earnings and Forecasts

In its latest quarterly report, released on 9/29/2023, the company reported earnings of -$0.45 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 27.06% per share during the next fiscal year.

Acutus Medical Inc (NASDAQ: AFIB) Trading Performance Indicators

Here are Acutus Medical Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.29.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.25, a number that is poised to hit -0.39 in the next quarter and is forecasted to reach -1.56 in one year’s time.

Technical Analysis of Acutus Medical Inc (AFIB)

Compared to the last year’s volume of 3.22 million, its volume of 0.57 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 37.04%. Additionally, its Average True Range was 0.03.

During the past 100 days, Acutus Medical Inc’s (AFIB) raw stochastic average was set at 6.02%, which indicates a significant decrease from 10.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 240.36% in the past 14 days, which was higher than the 193.51% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.2013, while its 200-day Moving Average is $0.5562. Nevertheless, the first resistance level for the watch stands at $0.2119 in the near term. At $0.2258, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.2417. If the price goes on to break the first support level at $0.1821, it is likely to go to the next support level at $0.1662. Should the price break the second support level, the third support level stands at $0.1523.

Acutus Medical Inc (NASDAQ: AFIB) Key Stats

With a market capitalization of 5.80 million, the company has a total of 29,304K Shares Outstanding. Currently, annual sales are 16,360 K while annual income is -39,620 K. The company’s previous quarter sales were 5,240 K while its latest quarter income was -13,240 K.